SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-108442
Filing Date
2009-05-12
Accepted
2009-05-12 15:07:18
Documents
10
Effectiveness Date
2009-05-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddfan14a.htm DFAN14A 12021
2 PRESS RELEASE dex991.htm EX-99.1 29933
3 GRAPHIC g55771g03u34.jpg GRAPHIC 53365
4 GRAPHIC g55771g09m58.jpg GRAPHIC 11228
5 GRAPHIC g55771g66d81.jpg GRAPHIC 7532
6 GRAPHIC g55771g71e15.jpg GRAPHIC 49322
7 GRAPHIC g55771g80g08.jpg GRAPHIC 53214
8 GRAPHIC g55771g96a62.jpg GRAPHIC 49911
9 GRAPHIC g55771g96l88.jpg GRAPHIC 73090
10 GRAPHIC g55771g99x54.jpg GRAPHIC 47445
  Complete submission text file 0001193125-09-108442.txt   520589
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-19700 | Film No.: 09818486
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1101 FIFTH AVENUE SUITE 370 SAN RAFAEL CA 94901
Business Address 1101 FIFTH AVENUE SUITE 370 SAN RAFAEL CA 94901 4154481200
EASTBOURNE CAPITAL MANAGEMENT LLC/CA (Filed by) CIK: 0001140888 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DFAN14A